Pharmacokinetics and antitumor efficacy of XMT-1001, a novel, polymeric topoisomerase I inhibitor, in mice bearing HT-29 human colon carcinoma xenografts.

Pharmacokinetics and antitumor efficacy of XMT-1001, a novel, polymeric topoisomerase I inhibitor, in mice bearing HT-29 human colon carcinoma xenografts.

Item
http://www.wikidata.org/entity/Q34258910
Phase 1 evaluation of EZN-2208, a polyethylene glycol conjugate of SN38, in children adolescents and young adults with relapsed or refractory solid tumors.Synergistic anti-tumor effects of combined gemcitabine and cisplatin nanoparticles in a stroma-rich bladder carcinoma model.Pharmacokinetics and efficacy of PEGylated liposomal doxorubicin in an intracranial model of breast cancer.Evaluation of the efficiency of tumor and tissue delivery of carrier-mediated agents (CMA) and small molecule (SM) agents in mice using a novel pharmacokinetic (PK) metric: relative distribution index over time (RDI-OT).Challenges and opportunities in the advancement of nanomedicines.Nanoparticle drug loading as a design parameter to improve docetaxel pharmacokinetics and efficacyTherapeutic nanoparticles in clinics and under clinical evaluation.Clinical advances of nanocarrier-based cancer therapy and diagnostics.An overview of quinoline as a privileged scaffold in cancer drug discovery.Complex effects of tumor microenvironment on the tumor disposition of carrier-mediated agents.Efficacy and pharmacokinetics of a modified acid-labile docetaxel-PRINT(®) nanoparticle formulation against non-small-cell lung cancer brain metastases.Natural Products as a Vital Source for the Discovery of Cancer Chemotherapeutic and Chemopreventive AgentsSupramolecular chemotherapy based on host-guest molecular recognition: a novel strategy in the battle against cancer with a bright future.Silver nanoparticle conjugation affects antiacanthamoebic activities of amphotericin B, nystatin, and fluconazole.
P2860

Pharmacokinetics and antitumor efficacy of XMT-1001, a novel, polymeric topoisomerase I inhibitor, in mice bearing HT-29 human colon carcinoma xenografts.

Item
http://www.wikidata.org/entity/Q34258910
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Pharmacokinetics and antitumor ...... an colon carcinoma xenografts.
@ast
Pharmacokinetics and antitumor ...... an colon carcinoma xenografts.
@en
Pharmacokinetics and antitumor ...... an colon carcinoma xenografts.
@nl
type
label
Pharmacokinetics and antitumor ...... an colon carcinoma xenografts.
@ast
Pharmacokinetics and antitumor ...... an colon carcinoma xenografts.
@en
Pharmacokinetics and antitumor ...... an colon carcinoma xenografts.
@nl
prefLabel
Pharmacokinetics and antitumor ...... an colon carcinoma xenografts.
@ast
Pharmacokinetics and antitumor ...... an colon carcinoma xenografts.
@en
Pharmacokinetics and antitumor ...... an colon carcinoma xenografts.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P356
P1433
P1476
Pharmacokinetics and antitumor ...... an colon carcinoma xenografts.
@en
P2093
P304
P31
P356
10.1158/1078-0432.CCR-11-1554
P407
P433
P478
P577
P698